Soleno Therapeutics (SLNO)

• Market cap: $1.74B
• 1 day: -8.11%
• 5 days: -14.18%
• 1 month: -9.34%
• 3 months: -32.41%
• 6 months: -34.02%
• Year to date: -28.43%
• 1 year: -31.14%
• 5 years: 34.77%
• 10 years: -63.4%
• Sector: Healthcare
• Industry: Biotechnology

About: Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue. The company's reporting segment focused on the development and commercialization of its sole therapeutic product, VYKAT XR.

Employees: 182